| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 6.08e-14 | 17 | 227 | 9 | GO:0005132 | |
| GeneOntologyMolecularFunction | cytokine activity | IL16 GDF6 PF4V1 IL17F BMP10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 1.12e-06 | 250 | 227 | 14 | GO:0005125 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP5PF MYH3 ERCC2 ATP8B1 SRCAP RUVBL2 KIF9 DDX18 NAV2 MYO18A ABCC6 CHD5 EIF4A2 ABCB8 MACF1 ABCC12 ATP5F1C | 1.28e-05 | 441 | 227 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | cytokine receptor binding | PF4V1 IL17F CCR2 SHC1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 MADD IFNA14 IFNA17 IFNA21 IFNW1 | 2.19e-05 | 324 | 227 | 14 | GO:0005126 |
| GeneOntologyMolecularFunction | microtubule binding | REEP1 FTCD REEP2 KIF9 ALMS1 CAMSAP3 CCDC187 TUBGCP6 CCDC88C LRPPRC MACF1 REEP4 | 2.23e-04 | 308 | 227 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5PF MYH3 ERCC2 ATP8B1 SRCAP RUVBL2 KIF9 DDX18 NAV2 ATP6V1C2 MYO18A ABCC6 CHD5 EIF4A2 ABCB8 MACF1 ABCC12 ATP5F1C | 2.43e-04 | 614 | 227 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity | 3.83e-04 | 3 | 227 | 2 | GO:0015018 | |
| GeneOntologyMolecularFunction | tubulin binding | REEP1 FTCD REEP2 KIF9 ALMS1 DIP2B CAMSAP3 CCDC187 TUBGCP6 CCDC88C LRPPRC MACF1 REEP4 HTT | 4.10e-04 | 428 | 227 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | protein kinase A binding | 5.10e-04 | 58 | 227 | 5 | GO:0051018 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP5PF MYH3 ERCC2 BMS1 ATP8B1 SRCAP RUVBL2 KIF9 DDX18 NAV2 GNA11 GNAQ MYO18A ABCC6 CHD5 EIF4A2 ABCB8 MACF1 ABCC12 ATP5F1C | 5.72e-04 | 775 | 227 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 5.96e-04 | 15 | 227 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH3 REEP1 FTCD REEP2 IQGAP1 KIF9 ALMS1 BMP10 SCN5A MYO18B WASF1 DIP2B FLNC CAMSAP3 MYO18A CCDC187 TCAP TUBGCP6 CCDC88C LRPPRC MACF1 ARPC5L REEP4 HTT PHACTR1 | 7.64e-04 | 1099 | 227 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRG3 ATP5PF KCNE5 PKDREJ RYR2 TRPM3 SCN5A SCN9A SLC17A7 TRPM8 GABRR3 CACNA1E SLC4A11 ATP5F1C | 8.14e-04 | 459 | 227 | 14 | GO:0005216 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 5.09e-13 | 21 | 226 | 9 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 2.20e-12 | 24 | 226 | 9 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 1.12e-11 | 28 | 226 | 9 | GO:0042501 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 STX11 | 2.21e-11 | 42 | 226 | 10 | GO:0002323 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 7.97e-09 | 55 | 226 | 9 | GO:0043330 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 AKAP9 DOCK7 | 1.43e-08 | 101 | 226 | 11 | GO:0033138 |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.75e-08 | 63 | 226 | 9 | GO:0043331 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | USP18 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 3.12e-08 | 85 | 226 | 10 | GO:0060337 |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | USP18 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 3.50e-08 | 86 | 226 | 10 | GO:0071357 |
| GeneOntologyBiologicalProcess | response to type I interferon | USP18 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 6.73e-08 | 92 | 226 | 10 | GO:0034340 |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | PF4V1 CCR2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 STX11 | 8.80e-08 | 148 | 226 | 12 | GO:0002286 |
| GeneOntologyBiologicalProcess | natural killer cell activation | PTPN22 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 STX11 | 1.22e-07 | 124 | 226 | 11 | GO:0030101 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 AKAP9 DOCK7 | 3.38e-07 | 137 | 226 | 11 | GO:0033135 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 4.23e-07 | 63 | 226 | 8 | GO:0050691 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | USP18 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 4.36e-07 | 112 | 226 | 10 | GO:0140888 |
| GeneOntologyBiologicalProcess | cellular response to virus | 6.35e-07 | 90 | 226 | 9 | GO:0098586 | |
| GeneOntologyBiologicalProcess | B cell proliferation | IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 SIGLEC11 | 1.12e-06 | 124 | 226 | 10 | GO:0042100 |
| GeneOntologyBiologicalProcess | B cell differentiation | EZH2 ONECUT1 DOCK10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 2.36e-06 | 201 | 226 | 12 | GO:0030183 |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | PF4V1 CCR2 DOCK10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 STX11 | 4.30e-06 | 251 | 226 | 13 | GO:0002285 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 6.58e-06 | 90 | 226 | 8 | GO:0050688 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 9.87e-06 | 125 | 226 | 9 | GO:0046425 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | PF4V1 ADGRE2 GAB2 CCR2 DOCK10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 STX11 | 1.15e-05 | 361 | 226 | 15 | GO:0002366 |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | PF4V1 ADGRE2 GAB2 CCR2 DOCK10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 STX11 | 1.31e-05 | 365 | 226 | 15 | GO:0002263 |
| GeneOntologyBiologicalProcess | B cell activation | AKAP17A EZH2 ONECUT1 DOCK10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 SIGLEC11 | 2.58e-05 | 341 | 226 | 14 | GO:0042113 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 2.90e-05 | 143 | 226 | 9 | GO:1904892 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | SMG1 EIF2AK3 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 AKAP9 DOCK7 | 3.65e-05 | 307 | 226 | 13 | GO:0018105 |
| GeneOntologyBiologicalProcess | regulation of NMDA receptor activity | 3.81e-05 | 18 | 226 | 4 | GO:2000310 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SMG1 EIF2AK3 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 AKAP9 DOCK7 | 5.41e-05 | 319 | 226 | 13 | GO:0018209 |
| GeneOntologyBiologicalProcess | humoral immune response | PF4V1 IL17F CCR2 C8B IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 5.77e-05 | 321 | 226 | 13 | GO:0006959 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH3 KCNE5 RYR2 IQGAP1 SIRPG ALMS1 BMP10 SCN5A SCN9A IQSEC1 MYO18B WASF1 FLNC CARMIL2 SHC1 MYO18A ARHGEF18 SPECC1L TCAP CCDC88C AKAP9 ARPC5L GRHL3 PHACTR1 | 6.79e-05 | 912 | 226 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | CCR2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 6.90e-05 | 198 | 226 | 10 | GO:0007259 |
| GeneOntologyBiologicalProcess | endoplasmic reticulum tubular network organization | 8.79e-05 | 22 | 226 | 4 | GO:0071786 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | PF4V1 PTPN22 EZH2 ONECUT1 CCR2 CARMIL2 DOCK10 AMBRA1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 9.51e-05 | 537 | 226 | 17 | GO:0030098 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | CCR2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 1.42e-04 | 216 | 226 | 10 | GO:0097696 |
| GeneOntologyBiologicalProcess | establishment of sister chromatid cohesion | 2.01e-04 | 11 | 226 | 3 | GO:0034085 | |
| GeneOntologyBiologicalProcess | immune effector process | PF4V1 PTPN22 ADGRE2 IL17F GAB2 CCR2 C8B IGHV1-45 MYO18A DOCK10 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 SIGLEC11 STX11 MUC4 | 2.02e-04 | 859 | 226 | 22 | GO:0002252 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH3 IQGAP1 ALMS1 BMP10 MYO18B FLNC MYO18A ARHGEF18 TCAP PHACTR1 | 3.20e-04 | 239 | 226 | 10 | GO:0031032 |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRG3 NAT8L EZH2 SHC3 CCR2 IQSEC1 SLC17A7 GNA11 GNAQ BSN GABRR3 MPP2 CACNA1E RASGRF1 CRHBP STX19 SNCAIP AKAP9 HRH4 RAPGEF2 RIMS2 STX11 HTT | 4.72e-04 | 976 | 226 | 23 | GO:0099536 |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | PTPN22 CCR2 CARMIL2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 SIGLEC11 | 4.74e-04 | 398 | 226 | 13 | GO:0046651 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.08e-04 | 127 | 226 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 5.23e-04 | 167 | 226 | 8 | GO:0060048 | |
| GeneOntologyCellularComponent | centriole | 2.01e-05 | 172 | 228 | 10 | GO:0005814 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 DAPK1 DGKH IQGAP1 KIF9 PTPN12 MYO18B TAF5 WASF1 ONECUT2 FLNC CARMIL2 MYO18A SPECC1L ACTR1A INTS6 MACF1 ARPC5L | 6.60e-05 | 576 | 228 | 18 | GO:0015629 |
| Domain | Interferon | 1.15e-13 | 17 | 228 | 9 | PF00143 | |
| Domain | INTERFERON_A_B_D | 1.15e-13 | 17 | 228 | 9 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 1.15e-13 | 17 | 228 | 9 | IPR000471 | |
| Domain | IFabd | 1.15e-13 | 17 | 228 | 9 | SM00076 | |
| Domain | - | 8.34e-09 | 50 | 228 | 9 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.00e-08 | 51 | 228 | 9 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | ZNF547 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 2.19e-08 | 74 | 228 | 10 | IPR009079 |
| Domain | PID_Shc-like | 7.12e-06 | 4 | 228 | 3 | IPR006019 | |
| Domain | IQ_motif_EF-hand-BS | 1.43e-05 | 90 | 228 | 8 | IPR000048 | |
| Domain | IQ | 1.82e-05 | 93 | 228 | 8 | PS50096 | |
| Domain | ARM-type_fold | SMG1 URB1 USP35 GCN1 NIPBL PPP4R1 DNAJC13 VEPH1 NBEA MEI1 SERAC1 EIF4G3 STAG3 STAG2 HTT | 1.92e-05 | 339 | 228 | 15 | IPR016024 |
| Domain | PH_dom-like | DGKH SHC3 GAB2 SHC2 IQSEC1 RASGRF1 ARHGAP23 VEPH1 SHC1 DOCK10 ARHGEF18 NBEA CNKSR2 BBS5 OSBPL3 IPCEF1 PLEKHA2 | 2.03e-05 | 426 | 228 | 17 | IPR011993 |
| Domain | IQ | 2.52e-05 | 71 | 228 | 7 | PF00612 | |
| Domain | - | DGKH SHC3 GAB2 SHC2 IQSEC1 RASGRF1 ARHGAP23 VEPH1 SHC1 DOCK10 ARHGEF18 CNKSR2 BBS5 OSBPL3 IPCEF1 PLEKHA2 | 2.64e-05 | 391 | 228 | 16 | 2.30.29.30 |
| Domain | ARM-like | SMG1 USP35 GCN1 NIPBL PPP4R1 DNAJC13 DOCK10 NBEA MEI1 SERAC1 STAG3 STAG2 HTT | 2.91e-05 | 270 | 228 | 13 | IPR011989 |
| Domain | TB2_DP1_HVA22 | 3.49e-05 | 6 | 228 | 3 | IPR004345 | |
| Domain | TB2_DP1_HVA22 | 3.49e-05 | 6 | 228 | 3 | PF03134 | |
| Domain | IQ | 5.95e-05 | 81 | 228 | 7 | SM00015 | |
| Domain | Myosin-like_IQ_dom | 7.26e-05 | 19 | 228 | 4 | IPR027401 | |
| Domain | - | 7.26e-05 | 19 | 228 | 4 | 4.10.270.10 | |
| Domain | PH | DGKH GAB2 IQSEC1 RASGRF1 ARHGAP23 VEPH1 DOCK10 ARHGEF18 CNKSR2 OSBPL3 IPCEF1 PLEKHA2 | 1.66e-04 | 278 | 228 | 12 | SM00233 |
| Domain | PH_DOMAIN | DGKH GAB2 IQSEC1 RASGRF1 ARHGAP23 VEPH1 DOCK10 ARHGEF18 CNKSR2 OSBPL3 IPCEF1 PLEKHA2 | 1.72e-04 | 279 | 228 | 12 | PS50003 |
| Domain | PH_domain | DGKH GAB2 IQSEC1 RASGRF1 ARHGAP23 VEPH1 DOCK10 ARHGEF18 CNKSR2 OSBPL3 IPCEF1 PLEKHA2 | 1.77e-04 | 280 | 228 | 12 | IPR001849 |
| Domain | CH | 2.12e-04 | 70 | 228 | 6 | PF00307 | |
| Domain | HEAT_REPEAT | 2.12e-04 | 70 | 228 | 6 | PS50077 | |
| Domain | CH | 2.67e-04 | 73 | 228 | 6 | PS50021 | |
| Domain | P-loop_NTPase | MYH3 ERCC2 BMS1 DAPK1 PFKFB2 SRCAP RUVBL2 IQGAP1 KIF9 AK5 DDX18 NAV2 GNA11 GNAQ MYO18B MPP2 MYO18A ABCC6 CHD5 EIF4A2 ABCB8 ABCC12 DSEL | 2.98e-04 | 848 | 228 | 23 | IPR027417 |
| Domain | CH-domain | 3.09e-04 | 75 | 228 | 6 | IPR001715 | |
| Domain | PDZ | 3.43e-04 | 141 | 228 | 8 | PF00595 | |
| Domain | Glyco_trans_43 | 4.42e-04 | 3 | 228 | 2 | IPR005027 | |
| Domain | Glyco_transf_43 | 4.42e-04 | 3 | 228 | 2 | PF03360 | |
| Domain | PDZ | 4.75e-04 | 148 | 228 | 8 | SM00228 | |
| Domain | PH | DGKH GAB2 RASGRF1 VEPH1 DOCK10 ARHGEF18 CNKSR2 OSBPL3 IPCEF1 PLEKHA2 | 5.29e-04 | 229 | 228 | 10 | PF00169 |
| Domain | PDZ | 5.43e-04 | 151 | 228 | 8 | PS50106 | |
| Domain | PDZ | 5.67e-04 | 152 | 228 | 8 | IPR001478 | |
| Domain | HEAT | 7.02e-04 | 58 | 228 | 5 | IPR000357 | |
| Domain | OAR | 7.33e-04 | 15 | 228 | 3 | PF03826 | |
| Domain | SCD | 8.76e-04 | 4 | 228 | 2 | PS51425 | |
| Domain | SCD | 8.76e-04 | 4 | 228 | 2 | IPR020839 | |
| Domain | STAG | 8.76e-04 | 4 | 228 | 2 | PF08514 | |
| Domain | STAG | 8.76e-04 | 4 | 228 | 2 | IPR013721 | |
| Domain | Gprotein_alpha_Q | 8.76e-04 | 4 | 228 | 2 | IPR000654 | |
| Domain | OAR | 8.94e-04 | 16 | 228 | 3 | PS50803 | |
| Domain | OAR_dom | 8.94e-04 | 16 | 228 | 3 | IPR003654 | |
| Domain | CH | 1.18e-03 | 65 | 228 | 5 | SM00033 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 4.92e-12 | 23 | 179 | 9 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 7.78e-12 | 24 | 179 | 9 | M47908 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 1.27e-11 | 17 | 179 | 8 | M47564 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.82e-11 | 26 | 179 | 9 | M982 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 2.27e-11 | 18 | 179 | 8 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 3.88e-11 | 19 | 179 | 8 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 6.39e-11 | 20 | 179 | 8 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.02e-10 | 21 | 179 | 8 | M47909 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.11e-10 | 31 | 179 | 9 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.59e-10 | 22 | 179 | 8 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.59e-10 | 22 | 179 | 8 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 2.41e-10 | 23 | 179 | 8 | M47452 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.80e-10 | 34 | 179 | 9 | MM15631 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 3.57e-10 | 24 | 179 | 8 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 3.57e-10 | 24 | 179 | 8 | M47576 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 6.43e-10 | 37 | 179 | 9 | M39785 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 1.45e-09 | 28 | 179 | 8 | MM1378 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 2.10e-09 | 19 | 179 | 7 | MM1571 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 2.66e-09 | 30 | 179 | 8 | M936 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 3.55e-09 | 31 | 179 | 8 | M47964 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.01e-08 | 35 | 179 | 8 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 1.01e-08 | 35 | 179 | 8 | M6382 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.53e-07 | 33 | 179 | 7 | MM1379 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | KIF9 WEE1 DOCK10 JMJD1C IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 DOCK7 | 2.53e-07 | 170 | 179 | 13 | M941 |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.66e-07 | 71 | 179 | 9 | M15913 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.70e-07 | 52 | 179 | 8 | M13103 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 4.23e-07 | 55 | 179 | 8 | M11844 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 5.17e-07 | 39 | 179 | 7 | MM15914 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 6.03e-07 | 78 | 179 | 9 | M973 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | PF4V1 IL17F IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 6.32e-07 | 127 | 179 | 11 | M42533 |
| Pathway | BIOCARTA_IL1R_PATHWAY | 7.39e-07 | 41 | 179 | 7 | MM1493 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | SHC3 SHC2 SHC1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 | 1.35e-06 | 137 | 179 | 11 | M5669 |
| Pathway | REACTOME_INTERFERON_SIGNALING | USP18 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 EIF4A2 EIF4G3 | 1.45e-06 | 138 | 179 | 11 | MM15635 |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.54e-06 | 87 | 179 | 9 | MM15915 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.57e-06 | 65 | 179 | 8 | M272 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 3.84e-06 | 73 | 179 | 8 | M39837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS | 4.97e-06 | 10 | 179 | 4 | M47930 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 9.25e-06 | 82 | 179 | 8 | M1002 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.56e-05 | 88 | 179 | 8 | M16004 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 3.23e-05 | 126 | 179 | 9 | M45009 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.44e-05 | 98 | 179 | 8 | M48247 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 4.59e-05 | 102 | 179 | 8 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 4.92e-05 | 103 | 179 | 8 | M39434 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 5.89e-05 | 136 | 179 | 9 | M42547 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 7.46e-05 | 81 | 179 | 7 | M748 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.45e-04 | 120 | 179 | 8 | M48233 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.46e-04 | 90 | 179 | 7 | MM14979 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.61e-04 | 155 | 179 | 9 | M17411 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.04e-04 | 95 | 179 | 7 | M6729 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.18e-04 | 96 | 179 | 7 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.33e-04 | 97 | 179 | 7 | M27478 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.79e-04 | 71 | 179 | 6 | MM15495 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | RPS28 IL17F IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 | 2.79e-04 | 204 | 179 | 10 | M45011 |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 3.01e-04 | 72 | 179 | 6 | M27749 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 4.07e-04 | 12 | 179 | 3 | MM14657 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | ATP5PF SFI1 MKS1 ALMS1 BBS5 CEP164 ACTR1A AKAP9 CEP250 ATP5F1C | 4.56e-04 | 217 | 179 | 10 | MM14708 |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | PF4V1 CCR2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 5.59e-04 | 264 | 179 | 11 | M9809 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 5.72e-04 | 184 | 179 | 9 | MM15145 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 6.87e-04 | 151 | 179 | 8 | M39801 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 7.35e-04 | 85 | 179 | 6 | MM14906 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | USP18 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 EIF4A2 EIF4G3 | 7.38e-04 | 273 | 179 | 11 | M983 |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 8.31e-04 | 87 | 179 | 6 | M27194 | |
| Pathway | PID_ARF6_PATHWAY | 9.68e-04 | 35 | 179 | 4 | M86 | |
| Pathway | REACTOME_HEMOSTASIS | PF4V1 DGKH SIRPG KIF9 GNA11 GNAQ WEE1 SHC1 DOCK10 JMJD1C IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 DOCK7 | 1.03e-03 | 679 | 179 | 19 | M8395 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.04e-03 | 200 | 179 | 9 | M864 | |
| Pathway | PID_TRKR_PATHWAY | 1.05e-03 | 61 | 179 | 5 | M187 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | ATP5PF SFI1 MKS1 ALMS1 CRTC3 BBS5 CEP164 ACTR1A AKAP9 CEP250 ATP5F1C | 1.46e-03 | 297 | 179 | 11 | M27050 |
| Pathway | REACTOME_SARS_COV_2_INFECTION | RPS28 IL17F IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 ACE2 | 1.54e-03 | 299 | 179 | 11 | M41727 |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.96e-03 | 20 | 179 | 3 | M12256 | |
| Pubmed | Characterization of the murine alpha interferon gene family. | 4.53e-17 | 14 | 233 | 9 | 15254193 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 2.56e-16 | 16 | 233 | 9 | 18414664 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.74e-15 | 12 | 233 | 8 | 16611902 | |
| Pubmed | 1.74e-15 | 12 | 233 | 8 | 8245849 | ||
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.74e-15 | 12 | 233 | 8 | 7530016 | |
| Pubmed | 1.74e-15 | 12 | 233 | 8 | 9794206 | ||
| Pubmed | 1.74e-15 | 12 | 233 | 8 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.74e-15 | 12 | 233 | 8 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.74e-15 | 12 | 233 | 8 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.74e-15 | 12 | 233 | 8 | 7684767 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.74e-15 | 12 | 233 | 8 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.74e-15 | 12 | 233 | 8 | 3758677 | |
| Pubmed | 1.74e-15 | 12 | 233 | 8 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.74e-15 | 12 | 233 | 8 | 8760352 | |
| Pubmed | 1.74e-15 | 12 | 233 | 8 | 17451966 | ||
| Pubmed | 2.03e-15 | 19 | 233 | 9 | 1385305 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 4.50e-15 | 13 | 233 | 8 | 12930842 | |
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 2471809 | ||
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 8438572 | ||
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 9343822 | ||
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 4.50e-15 | 13 | 233 | 8 | 2987810 | |
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 19130550 | ||
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 4.50e-15 | 13 | 233 | 8 | 2014240 | |
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 18005734 | ||
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 4.50e-15 | 13 | 233 | 8 | 6094686 | |
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 1655578 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 4.50e-15 | 13 | 233 | 8 | 23255800 | |
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 7523540 | ||
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 22739040 | ||
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 4.50e-15 | 13 | 233 | 8 | 18726328 | |
| Pubmed | 4.50e-15 | 13 | 233 | 8 | 18572754 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 1.04e-14 | 14 | 233 | 8 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 1.04e-14 | 14 | 233 | 8 | 7526537 | |
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 19559726 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 1.04e-14 | 14 | 233 | 8 | 7532202 | |
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 1.04e-14 | 14 | 233 | 8 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 1.04e-14 | 14 | 233 | 8 | 17517919 | |
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 25972534 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 7583919 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 2987811 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 8345204 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 19620305 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 15240719 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 16418394 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 18272764 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 11884139 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 19004943 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 14983024 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 21172865 | ||
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 1.04e-14 | 14 | 233 | 8 | 1381203 | |
| Pubmed | 1.07e-14 | 22 | 233 | 9 | 7913356 | ||
| Pubmed | 2.22e-14 | 15 | 233 | 8 | 8786318 | ||
| Pubmed | 2.22e-14 | 15 | 233 | 8 | 15684736 | ||
| Pubmed | 2.22e-14 | 15 | 233 | 8 | 9520456 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 2.22e-14 | 15 | 233 | 8 | 8661419 | |
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 2.22e-14 | 15 | 233 | 8 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 2.22e-14 | 15 | 233 | 8 | 18339807 | |
| Pubmed | Modulation of HIV-1 transcription by cytokines and chemokines. | 4.33e-14 | 25 | 233 | 9 | 16375755 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 4.42e-14 | 16 | 233 | 8 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 4.42e-14 | 16 | 233 | 8 | 7904170 | |
| Pubmed | 8.30e-14 | 17 | 233 | 8 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 8.30e-14 | 17 | 233 | 8 | 15233997 | |
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 9.82e-14 | 27 | 233 | 9 | 30936491 | |
| Pubmed | 1.49e-13 | 18 | 233 | 8 | 1905933 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.78e-13 | 11 | 233 | 7 | 6444699 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.78e-13 | 11 | 233 | 7 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.78e-13 | 11 | 233 | 7 | 15795237 | |
| Pubmed | 1.78e-13 | 11 | 233 | 7 | 9794439 | ||
| Pubmed | 1.78e-13 | 11 | 233 | 7 | 18835032 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.78e-13 | 11 | 233 | 7 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.78e-13 | 11 | 233 | 7 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.78e-13 | 11 | 233 | 7 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.78e-13 | 11 | 233 | 7 | 3456887 | |
| Pubmed | 1.78e-13 | 11 | 233 | 7 | 25310498 | ||
| Pubmed | 2.55e-13 | 19 | 233 | 8 | 7815507 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 2.55e-13 | 19 | 233 | 8 | 1708818 | |
| Pubmed | 2.55e-13 | 19 | 233 | 8 | 7511078 | ||
| Pubmed | 2.55e-13 | 19 | 233 | 8 | 17360657 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 4.23e-13 | 20 | 233 | 8 | 11694501 | |
| Pubmed | 4.23e-13 | 20 | 233 | 8 | 8764000 | ||
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 4.26e-13 | 12 | 233 | 7 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 4.26e-13 | 12 | 233 | 7 | 27988795 | |
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 8656058 | ||
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 6188104 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 4.26e-13 | 12 | 233 | 7 | 18716002 | |
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 30967261 | ||
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 17434974 | ||
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 3017340 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 4.26e-13 | 12 | 233 | 7 | 1360280 | |
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 7601556 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 4.26e-13 | 12 | 233 | 7 | 21320124 | |
| Pubmed | 4.26e-13 | 12 | 233 | 7 | 9425112 | ||
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 4.26e-13 | 12 | 233 | 7 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 4.26e-13 | 12 | 233 | 7 | 7925651 | |
| Interaction | AGAP2 interactions | IQGAP1 AK5 KCTD16 IQSEC1 GNA11 GNAQ WASF1 CACNA1E ARHGEF18 NBEA CNKSR2 MACF1 RAPGEF2 RIMS2 PHACTR1 | 1.68e-08 | 210 | 227 | 15 | int:AGAP2 |
| Interaction | IFNA5 interactions | 1.23e-07 | 22 | 227 | 6 | int:IFNA5 | |
| Interaction | YWHAG interactions | REEP1 AKAP17A PFKFB2 PAK6 EZH2 RUVBL2 REEP2 GAB2 IQGAP1 ALMS1 IQSEC1 NAV2 BRD1 WASF1 JCAD CRTC3 CARMIL2 ARHGAP23 WEE1 CAMSAP3 SHC1 R3HDM2 SPECC1L HEXIM1 CCDC88C AKAP9 OSBPL3 CEP250 DOCK7 MACF1 PLEKHA2 USP54 REEP4 RAPGEF2 EIF4G3 HTT | 1.85e-07 | 1248 | 227 | 36 | int:YWHAG |
| Interaction | YWHAE interactions | REEP1 PSMD3 PFKFB2 PAK6 EZH2 RUVBL2 REEP2 GAB2 IQGAP1 NAV2 BRD1 WASF1 JCAD CRTC3 CARMIL2 RASGRF1 CAMSAP3 SHC1 R3HDM2 FASTKD2 HEXIM1 CCDC88C ACE2 ACTR1A AKAP9 OSBPL3 CEP250 DOCK7 MACF1 PLEKHA2 USP54 REEP4 RAPGEF2 RIMS2 HTT | 6.30e-07 | 1256 | 227 | 35 | int:YWHAE |
| Interaction | IFNA1 interactions | 6.85e-07 | 16 | 227 | 5 | int:IFNA1 | |
| Interaction | IFNA6 interactions | 1.06e-06 | 8 | 227 | 4 | int:IFNA6 | |
| Interaction | YWHAQ interactions | PDE3A DAPK1 PFKFB2 PAK6 EZH2 RUVBL2 GAB2 IQGAP1 NAV2 BRD1 GCN1 JCAD CRTC3 CARMIL2 ARHGAP23 WEE1 CAMSAP3 R3HDM2 SPECC1L HEXIM1 CCDC88C ACE2 LRPPRC OSBPL3 CEP250 DOCK7 MACF1 PLEKHA2 USP54 REEP4 RAPGEF2 HTT | 1.14e-06 | 1118 | 227 | 32 | int:YWHAQ |
| Interaction | YWHAZ interactions | REEP1 PFKFB2 PAK6 EZH2 REEP2 GAB2 AK5 KCTD16 NAV2 BRD1 WASF1 JCAD CRTC3 CARMIL2 RASGRF1 WEE1 CAMSAP3 MYO18A ARHGEF18 R3HDM2 CNKSR2 HEXIM1 MADD CCDC88C ACE2 LRPPRC AKAP9 OSBPL3 DOCK7 MACF1 PLEKHA2 USP54 REEP4 RAPGEF2 HTT | 1.93e-06 | 1319 | 227 | 35 | int:YWHAZ |
| Interaction | YWHAH interactions | PFKFB2 PAK6 REEP2 GAB2 IQGAP1 ALMS1 NAV2 BRD1 WASF1 JCAD DIP2B CRTC3 CARMIL2 WEE1 CAMSAP3 R3HDM2 SPECC1L MADD CCDC88C SNCAIP AKAP9 OSBPL3 DOCK7 MACF1 PLEKHA2 USP54 REEP4 RAPGEF2 EIF4G3 RIMS2 HTT | 2.46e-06 | 1102 | 227 | 31 | int:YWHAH |
| Interaction | YWHAB interactions | DAPK1 PFKFB2 PAK6 EZH2 REEP2 GAB2 IQGAP1 NAV2 BRD1 WASF1 CRTC3 CARMIL2 RASGRF1 ARHGAP23 WEE1 CAMSAP3 R3HDM2 CCDC88C ACE2 ACTR1A AKAP9 OSBPL3 DOCK7 MACF1 PLEKHA2 USP54 REEP4 RAPGEF2 HTT | 3.89e-06 | 1014 | 227 | 29 | int:YWHAB |
| Interaction | IFNA14 interactions | 2.57e-05 | 16 | 227 | 4 | int:IFNA14 | |
| Interaction | ISG15 interactions | USP18 ERCC2 PSMD3 EZH2 RUVBL2 IQGAP1 GCN1 MYO18A SPECC1L IFNA2 IFNA4 IFNA5 IFNA10 IFNA14 IFNA21 IFNW1 SUPT16H | 4.80e-05 | 494 | 227 | 17 | int:ISG15 |
| Interaction | BBS7 interactions | 4.91e-05 | 85 | 227 | 7 | int:BBS7 | |
| Interaction | KDR interactions | 5.23e-05 | 150 | 227 | 9 | int:KDR | |
| Cytoband | 9p22 | 3.79e-15 | 25 | 234 | 9 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 1.70e-08 | 124 | 234 | 9 | chr9p21 | |
| GeneFamily | Interferons | 6.62e-12 | 32 | 161 | 9 | 598 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | DGKH GAB2 RASGRF1 ARHGAP23 VEPH1 DOCK10 ARHGEF18 CNKSR2 OSBPL3 IPCEF1 PLEKHA2 | 2.41e-06 | 206 | 161 | 11 | 682 |
| GeneFamily | Receptor accessory proteins | 1.36e-05 | 6 | 161 | 3 | 717 | |
| GeneFamily | Myosins, class XVIII | 7.88e-05 | 2 | 161 | 2 | 1107 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.21e-04 | 29 | 161 | 4 | 396 | |
| GeneFamily | Beta-1,3-glucuronyltransferases | 2.35e-04 | 3 | 161 | 2 | 423 | |
| GeneFamily | PDZ domain containing | 4.28e-04 | 152 | 161 | 7 | 1220 | |
| GeneFamily | Cohesin complex | 2.13e-03 | 8 | 161 | 2 | 1060 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 2.72e-03 | 9 | 161 | 2 | 527 | |
| GeneFamily | INO80 complex |SRCAP complex | 2.72e-03 | 9 | 161 | 2 | 1329 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.72e-03 | 9 | 161 | 2 | 1203 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 1.10e-10 | 29 | 229 | 8 | MM586 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 3.43e-08 | 80 | 229 | 9 | MM646 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 4.30e-08 | 39 | 229 | 7 | M41095 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 5.87e-08 | 85 | 229 | 9 | MM684 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 7.20e-08 | 87 | 229 | 9 | MM652 | |
| Coexpression | NABA_SECRETED_FACTORS | IL16 GDF6 PF4V1 IL17F BMP10 IFNA2 IFNA4 CRHBP IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 3.31e-07 | 338 | 229 | 15 | MM17064 |
| Coexpression | NABA_SECRETED_FACTORS | IL16 GDF6 PF4V1 IL17F BMP10 IFNA2 IFNA4 CRHBP IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 IFNW1 | 3.99e-07 | 343 | 229 | 15 | M5883 |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 5.07e-07 | 80 | 229 | 8 | MM1229 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 9.44e-06 | 196 | 229 | 10 | M7672 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | ERCC2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA14 IFNA17 IFNA21 SIGLEC1 | 1.72e-05 | 210 | 229 | 10 | MM751 |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 2.07e-05 | 131 | 229 | 8 | MM1127 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | REEP1 ONECUT1 REEP2 RYR2 SORCS1 URB1 AK5 SCN9A BSN MPP2 ONECUT2 CACNA1E NBEA AKAP9 ZFHX4 CHD5 OGDHL RIMS2 | 5.08e-05 | 703 | 229 | 18 | M39070 |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN | 6.77e-05 | 199 | 229 | 9 | M4997 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 7.04e-05 | 200 | 229 | 9 | M8026 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 7.04e-05 | 200 | 229 | 9 | M5566 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SENSORY_NEURONS | 7.37e-05 | 116 | 229 | 7 | MM3649 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 8.51e-05 | 27 | 229 | 4 | M40935 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | MRPS31 MYH3 IL16 ERCC2 AKAP17A BMS1 PSMD3 SFI1 PFKFB2 EZH2 ONECUT1 CCR2 URB1 DDX18 GNAQ TAF5 BRD1 DNAJC13 DOCK10 ARHGEF18 CNKSR2 IFNW1 ALX1 OSBPL3 STAG2 B3GAT2 PHACTR1 | 9.34e-05 | 1394 | 229 | 27 | M9585 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NAT8L PAK6 RYR2 NELL2 KCTD16 SLC17A7 BSN CACNA1E MEI1 MADD CRACDL CHD5 | 3.32e-10 | 186 | 234 | 12 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NAT8L PAK6 RYR2 NELL2 KCTD16 SLC17A7 BSN CACNA1E RASGRF1 MADD CRACDL CHD5 | 5.07e-10 | 193 | 234 | 12 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NAT8L PAK6 RYR2 NELL2 KCTD16 SLC17A7 BSN CACNA1E RASGRF1 MADD CRACDL CHD5 | 5.07e-10 | 193 | 234 | 12 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NAT8L PAK6 RYR2 NELL2 KCTD16 SLC17A7 BSN CACNA1E RASGRF1 MADD CRACDL CHD5 | 5.07e-10 | 193 | 234 | 12 | 0c652ebe22ce5d2927599dd97ef1920547858395 |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | DRGX SHC3 SORCS1 NELL2 TRPM3 SCN9A ONECUT2 DOCK10 RLBP1 B3GAT1 RIMS2 | 2.89e-09 | 178 | 234 | 11 | 38ffbd01230c99f52274424ee6c172381daffc73 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | RYR2 SORCS1 NELL2 TRPM3 SLC17A7 WASF1 NPAS2 CNKSR2 CRACDL RIMS2 PHACTR1 | 7.50e-09 | 195 | 234 | 11 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | DAPK1 NELL2 NAV2 VEPH1 CAMSAP3 MBIP STX19 FSD1L AKAP9 OGDHL USP54 | 8.33e-09 | 197 | 234 | 11 | 44a59dfb889577b3160a5b13ada1276771a00241 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | DAPK1 TRPM3 NAV2 PLXNA1 VEPH1 MBIP FSD1L OSBPL3 OGDHL USP54 SLC4A11 | 9.75e-09 | 200 | 234 | 11 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-08 | 179 | 234 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SFI1 RYR2 SORCS1 TRPM3 SCN9A ONECUT2 FAT4 CNKSR2 LOXHD1 ZFHX4 | 5.18e-08 | 184 | 234 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SFI1 RYR2 SORCS1 TRPM3 SCN9A ONECUT2 FAT4 CNKSR2 LOXHD1 ZFHX4 | 5.18e-08 | 184 | 234 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SFI1 RYR2 SORCS1 TRPM3 SCN9A ONECUT2 FAT4 CNKSR2 LOXHD1 ZFHX4 | 5.18e-08 | 184 | 234 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | DRGX REEP2 SORCS1 NELL2 SCN9A ONECUT2 DOCK10 RLBP1 B3GAT1 RIMS2 | 5.46e-08 | 185 | 234 | 10 | 512f489daeb3b72d4578dc6f4d0ebb5f38d5bbab |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SMG1 ADGRE2 IQGAP1 CCR2 NIPBL DOCK10 JMJD1C MACF1 EIF4G3 STAG2 | 5.46e-08 | 185 | 234 | 10 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | RYR2 NELL2 SLC17A7 JCAD CACNA1E R3HDM2 CNKSR2 IPCEF1 CRACDL PHACTR1 | 5.74e-08 | 186 | 234 | 10 | 56c139e679d640ea901ead657a8e8887e0fca098 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | GABRG3 SORCS1 NELL2 TRPM3 WASF1 RASGRF1 NBEA EIF4A2 B3GAT1 RIMS2 | 9.84e-08 | 197 | 234 | 10 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | GABRG3 SORCS1 NELL2 TRPM3 WASF1 RASGRF1 NBEA EIF4A2 B3GAT1 RIMS2 | 9.84e-08 | 197 | 234 | 10 | d20f29088e9afd8a960d6f680075c380e550f8a7 |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.75e-07 | 168 | 234 | 9 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 169 | 234 | 9 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.16e-07 | 181 | 234 | 9 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.41e-07 | 182 | 234 | 9 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-07 | 182 | 234 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.66e-07 | 183 | 234 | 9 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-07 | 184 | 234 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 185 | 234 | 9 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 185 | 234 | 9 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-07 | 136 | 234 | 8 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.49e-07 | 186 | 234 | 9 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.78e-07 | 187 | 234 | 9 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 187 | 234 | 9 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 187 | 234 | 9 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 187 | 234 | 9 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | RYR2 SORCS1 NELL2 SLC17A7 WASF1 CNKSR2 CRACDL RAPGEF2 PHACTR1 | 7.09e-07 | 188 | 234 | 9 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | NELL2 AK5 SLC17A7 WASF1 CACNA1E RASGRF1 CNKSR2 CRACDL PHACTR1 | 7.41e-07 | 189 | 234 | 9 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 7.75e-07 | 190 | 234 | 9 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-07 | 190 | 234 | 9 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-07 | 190 | 234 | 9 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.46e-07 | 192 | 234 | 9 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.05e-06 | 197 | 234 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.14e-06 | 199 | 234 | 9 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.14e-06 | 199 | 234 | 9 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | RYR2 SORCS1 NELL2 SLC17A7 WASF1 CNKSR2 IPCEF1 CRACDL PHACTR1 | 1.19e-06 | 200 | 234 | 9 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 1.39e-06 | 105 | 234 | 7 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 3.23e-06 | 169 | 234 | 8 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.58e-06 | 182 | 234 | 8 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.05e-06 | 184 | 234 | 8 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.05e-06 | 184 | 234 | 8 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 186 | 234 | 8 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.55e-06 | 186 | 234 | 8 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 186 | 234 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 186 | 234 | 8 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.55e-06 | 186 | 234 | 8 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-06 | 187 | 234 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.81e-06 | 187 | 234 | 8 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.08e-06 | 188 | 234 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.08e-06 | 188 | 234 | 8 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.36e-06 | 189 | 234 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.36e-06 | 189 | 234 | 8 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.36e-06 | 189 | 234 | 8 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.65e-06 | 190 | 234 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.95e-06 | 191 | 234 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | NS-critical-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.26e-06 | 192 | 234 | 8 | cd34defac6565d34db507918e791b09c79f7d1f8 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.26e-06 | 192 | 234 | 8 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-06 | 192 | 234 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.26e-06 | 192 | 234 | 8 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.58e-06 | 193 | 234 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.58e-06 | 193 | 234 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-06 | 195 | 234 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.24e-06 | 195 | 234 | 8 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-06 | 195 | 234 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.59e-06 | 196 | 234 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.96e-06 | 197 | 234 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 198 | 234 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 198 | 234 | 8 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 198 | 234 | 8 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 198 | 234 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 198 | 234 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 198 | 234 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 198 | 234 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 198 | 234 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.03e-05 | 198 | 234 | 8 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-05 | 198 | 234 | 8 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 199 | 234 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 199 | 234 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 234 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 234 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.11e-05 | 200 | 234 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.11e-05 | 200 | 234 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 234 | 8 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-05 | 60 | 234 | 5 | 28415d543aaccc74d19e1bb92b7e6fa94f97f8f2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-05 | 60 | 234 | 5 | 71eba0fbef11cfc2b1c525d5f051530750e4fce9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.98e-05 | 157 | 234 | 7 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 2.06e-05 | 158 | 234 | 7 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 2.23e-05 | 160 | 234 | 7 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 2.23e-05 | 160 | 234 | 7 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.33e-05 | 161 | 234 | 7 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.33e-05 | 161 | 234 | 7 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.52e-05 | 163 | 234 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 168 | 234 | 7 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-05 | 169 | 234 | 7 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| Drug | CHEMBL466993 | 2.23e-11 | 32 | 231 | 9 | CID005320808 | |
| Drug | gunacin | 3.26e-11 | 14 | 231 | 7 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 6.07e-11 | 15 | 231 | 7 | CID000125229 | |
| Drug | ABMP | 1.33e-10 | 26 | 231 | 8 | CID000080567 | |
| Drug | podophyllin | 2.92e-10 | 18 | 231 | 7 | CID011979494 | |
| Drug | Nyco | 2.92e-10 | 18 | 231 | 7 | CID000071618 | |
| Drug | formosanin C | 1.51e-09 | 22 | 231 | 7 | CID000073597 | |
| Drug | Yfrkd | 2.13e-09 | 7 | 231 | 5 | CID000129984 | |
| Drug | Hiltonol | 2.16e-09 | 23 | 231 | 7 | CID000431963 | |
| Drug | cycloferon | 3.02e-09 | 24 | 231 | 7 | CID000038072 | |
| Drug | anagrelide | 3.74e-09 | 38 | 231 | 8 | CID000002182 | |
| Drug | hycanthone | 4.16e-09 | 25 | 231 | 7 | CID000003634 | |
| Drug | 1hiv | 5.62e-09 | 8 | 231 | 5 | CID005479205 | |
| Drug | Chebi:36708 | 5.62e-09 | 8 | 231 | 5 | CID011966289 | |
| Drug | inosiplex | 7.55e-09 | 27 | 231 | 7 | CID000037510 | |
| Drug | 1 ind | 8.72e-09 | 42 | 231 | 8 | CID003037877 | |
| Drug | Sesquimustard | 1.06e-08 | 43 | 231 | 8 | CID000019092 | |
| Drug | YNK01 | 1.15e-08 | 17 | 231 | 6 | CID000084071 | |
| Drug | adefovir | 1.65e-08 | 64 | 231 | 9 | CID000060172 | |
| Drug | poly rI:rC | 1.69e-08 | 30 | 231 | 7 | CID011979660 | |
| Drug | p203 | 1.71e-08 | 18 | 231 | 6 | CID000019228 | |
| Drug | pipobroman | 2.49e-08 | 10 | 231 | 5 | CID000004842 | |
| Drug | carprofen | 4.31e-08 | 34 | 231 | 7 | CID000002581 | |
| Drug | flesinoxan | 4.53e-08 | 11 | 231 | 5 | CID000057347 | |
| Drug | famciclovir | 5.10e-08 | 52 | 231 | 8 | CID000003324 | |
| Drug | tilorone | 5.34e-08 | 35 | 231 | 7 | CID000005475 | |
| Drug | Ampligen | 5.95e-08 | 53 | 231 | 8 | CID000038077 | |
| Drug | pyran | 8.03e-08 | 37 | 231 | 7 | CID000033703 | |
| Drug | isofagomine lactam | 1.18e-07 | 39 | 231 | 7 | CID000448980 | |
| Drug | Zinetac | 1.21e-07 | 80 | 231 | 9 | CID000005039 | |
| Drug | R 842 | 1.24e-07 | 13 | 231 | 5 | CID000130714 | |
| Drug | DTIC | 1.35e-07 | 81 | 231 | 9 | CID005281007 | |
| Drug | Lanicemine | 1.91e-07 | 14 | 231 | 5 | CID003038485 | |
| Drug | AC1O51IP | 3.44e-07 | 66 | 231 | 8 | CID006450363 | |
| Drug | copolymer 1 | 3.44e-07 | 66 | 231 | 8 | CID003081884 | |
| Drug | AC1L9AL3 | 3.86e-07 | 46 | 231 | 7 | CID000441122 | |
| Drug | entecavir | 4.50e-07 | 47 | 231 | 7 | CID000153941 | |
| Drug | DZNep | 4.95e-07 | 30 | 231 | 6 | CID000073087 | |
| Drug | U-10149A | NAV2 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA17 IFNW1 EIF4A2 RIMS2 | 5.25e-07 | 123 | 231 | 10 | CID000003928 |
| Drug | vinblastine | ATP8B1 PKDREJ PLXNA1 ABCC6 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 MADD IFNA17 IFNW1 | 5.60e-07 | 189 | 231 | 12 | CID000013342 |
| Drug | adefovir dipivoxil | 6.04e-07 | 49 | 231 | 7 | CID000060871 | |
| Drug | N6-methyl-(R)-roscovitine | 6.11e-07 | 71 | 231 | 8 | CID005289296 | |
| Drug | trifluorothymidine | 8.00e-07 | 51 | 231 | 7 | CID000006256 | |
| Drug | 2',3'-dideoxycytidine diphosphate | 8.43e-07 | 74 | 231 | 8 | CID000128494 | |
| Drug | leucovorin | 8.76e-07 | 130 | 231 | 10 | CID000000143 | |
| Drug | bropirimine | 9.17e-07 | 52 | 231 | 7 | CID000065457 | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | MRPS31 SFI1 RPS28 KDM6B SRCAP TRPM3 GNA11 WASF1 RASGRF1 WEE1 RLBP1 MACF1 | 9.18e-07 | 198 | 231 | 12 | 169_DN |
| Drug | 5H-purin-2-amine | 9.85e-07 | 102 | 231 | 9 | CID000409844 | |
| Drug | mu-I | 1.27e-06 | 78 | 231 | 8 | CID011987863 | |
| Drug | lobucavir | 1.30e-06 | 35 | 231 | 6 | CID000060786 | |
| Drug | Ciluprevir [USAN] | 1.41e-06 | 20 | 231 | 5 | CID006450803 | |
| Drug | val-mCyd | 1.41e-06 | 20 | 231 | 5 | CID006918726 | |
| Drug | m IU | 1.54e-06 | 56 | 231 | 7 | CID006852123 | |
| Drug | FMAU | 1.83e-06 | 37 | 231 | 6 | CID000072327 | |
| Drug | 2-[amino-[(2R,3R)-4-(dibenzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 1.83e-06 | 37 | 231 | 6 | CID016040231 | |
| Drug | Halt | 1.83e-06 | 21 | 231 | 5 | CID000094635 | |
| Drug | L DO | 1.83e-06 | 21 | 231 | 5 | CID000097725 | |
| Drug | Lps2 | 1.96e-06 | 58 | 231 | 7 | CID000454710 | |
| Drug | AC1L1U53 | 2.47e-06 | 60 | 231 | 7 | CID000060907 | |
| Drug | NSC-218321 | 2.51e-06 | 114 | 231 | 9 | CID000004739 | |
| Drug | glycrrhizin | 2.67e-06 | 86 | 231 | 8 | CID000003495 | |
| Drug | ridostin | 2.90e-06 | 116 | 231 | 9 | CID011979623 | |
| Drug | AC1L1ZCT | 3.74e-06 | 24 | 231 | 5 | CID000038235 | |
| Drug | AC1L1HZP | 3.84e-06 | 64 | 231 | 7 | CID000004361 | |
| Drug | barium iodide | 4.09e-06 | 4 | 231 | 3 | CID000083684 | |
| Drug | LB80380 | 4.63e-06 | 25 | 231 | 5 | CID006480442 | |
| Drug | oligoadenylate | USP18 EIF2AK3 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA17 IFNW1 EIF4G3 | 4.85e-06 | 157 | 231 | 10 | CID000107918 |
| Drug | cycloleucine | 6.39e-06 | 69 | 231 | 7 | CID000002901 | |
| Drug | AC1O52EF | 6.87e-06 | 13 | 231 | 4 | CID006450817 | |
| Drug | VX-497 | 6.93e-06 | 27 | 231 | 5 | CID000153241 | |
| Drug | 9-cis-acitretin | 7.74e-06 | 71 | 231 | 7 | CID000041317 | |
| Drug | AC1NRD2B | 8.36e-06 | 28 | 231 | 5 | CID005289317 | |
| Drug | imiquimod | 8.39e-06 | 132 | 231 | 9 | CID000057469 | |
| Drug | morphine hydrochloride | GABRG3 SIRPG SCN9A SLC17A7 EIF2AK3 CACNA1E HBP1 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA17 IFNW1 HRH4 B3GAT1 B3GAT2 | 9.26e-06 | 481 | 231 | 17 | CID000004253 |
| Drug | polycytidylic acid | AK5 ABCC6 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA17 IFNW1 EIF4G3 | 9.31e-06 | 169 | 231 | 10 | CID000000314 |
| Drug | arabinosylthymine | 9.32e-06 | 73 | 231 | 7 | CID000065049 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 9.93e-06 | 49 | 231 | 6 | CID000365716 | |
| Drug | NM 108 | 1.00e-05 | 29 | 231 | 5 | CID000500901 | |
| Drug | B132 | 1.02e-05 | 5 | 231 | 3 | CID002734031 | |
| Drug | AC1L1J7E | PLXNA1 ABCC6 IFNA2 IFNA4 IFNA5 IFNA10 IFNA17 ACE2 IFNW1 STX11 | 1.03e-05 | 171 | 231 | 10 | CID000004900 |
| Drug | penciclovir | 1.19e-05 | 30 | 231 | 5 | CID000004725 | |
| Drug | Chemox general | 1.19e-05 | 30 | 231 | 5 | CID000020041 | |
| Drug | AC1MMF4B | 1.33e-05 | 77 | 231 | 7 | CID003260010 | |
| Drug | Leucine enkephalin | 1.57e-05 | 109 | 231 | 8 | CID000003903 | |
| Drug | rifampicin | CYP19A1 ONECUT1 POLR1B EIF2AK3 IFNA2 IFNA4 IFNA5 IFNA6 IFNA10 IFNA17 IFNW1 NPRL3 HTT | 1.61e-05 | 306 | 231 | 13 | CID005381226 |
| Drug | AC1L9FQV | 2.01e-05 | 82 | 231 | 7 | CID000444118 | |
| Drug | HCV-371 | 2.02e-05 | 6 | 231 | 3 | CID003013096 | |
| Drug | AC1Q5H8E | 2.22e-05 | 149 | 231 | 9 | CID000114813 | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.69e-05 | 191 | 231 | 10 | 5351_DN | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.94e-05 | 193 | 231 | 10 | 6809_UP | |
| Drug | 2'-deoxy-3'-thiacytidine | 2.96e-05 | 87 | 231 | 7 | CID000003877 | |
| Drug | MCNU | 3.00e-05 | 36 | 231 | 5 | CID000071741 | |
| Drug | A809128 | 3.00e-05 | 36 | 231 | 5 | CID003392279 | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | ERCC2 URB1 RAB3IL1 MPP2 FLNC FASTKD2 ZFHX4 CEP250 SIGLEC1 PHACTR1 | 3.82e-05 | 199 | 231 | 10 | 6783_UP |
| Drug | Gliclazide [21187-98-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.82e-05 | 199 | 231 | 10 | 2870_UP | |
| Drug | fotemustine | 3.93e-05 | 38 | 231 | 5 | CID000104799 | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 0.1uM; MCF7; HG-U133A | 3.98e-05 | 200 | 231 | 10 | 3_UP | |
| Drug | dipyridamole | 4.30e-05 | 162 | 231 | 9 | CID000003108 | |
| Drug | methimazole | 4.47e-05 | 126 | 231 | 8 | CID001349907 | |
| Drug | NMMA | 4.89e-05 | 94 | 231 | 7 | CID000170607 | |
| Disease | hereditary spastic paraplegia 31 (implicated_via_orthology) | 8.83e-06 | 6 | 227 | 3 | DOID:0110782 (implicated_via_orthology) | |
| Disease | Intellectual Disability | KDM6B TRPM3 IQSEC1 WASF1 CACNA1E NBEA SPECC1L ACE2 SUPT16H MACF1 SERAC1 STAG2 HTT PHACTR1 | 1.08e-05 | 447 | 227 | 14 | C3714756 |
| Disease | triglyceride change measurement, response to exercise | 3.65e-05 | 9 | 227 | 3 | EFO_0007681, EFO_0007768 | |
| Disease | Phakomatosis cesioflammea | 5.89e-05 | 2 | 227 | 2 | C3838883 | |
| Disease | Congenital hemangioma | 5.89e-05 | 2 | 227 | 2 | C0235753 | |
| Disease | chronic post-operative pain measurement | 5.89e-05 | 2 | 227 | 2 | EFO_0010640 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 5.89e-05 | 2 | 227 | 2 | C1274879 | |
| Disease | Global developmental delay | 7.96e-05 | 133 | 227 | 7 | C0557874 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.76e-04 | 3 | 227 | 2 | C0349788 | |
| Disease | age at menarche | UIMC1 CYP19A1 GAB2 TRIM66 ALMS1 TRPM3 USP35 GNAQ BSN MPP2 CPA5 MADD ZFHX4 EIF4G3 | 2.26e-04 | 594 | 227 | 14 | EFO_0004703 |
| Disease | migraine without aura, susceptibility to, 4 | 2.34e-04 | 16 | 227 | 3 | MONDO_0011847 | |
| Disease | Cutaneous Melanoma | 2.76e-04 | 41 | 227 | 4 | C0151779 | |
| Disease | immature platelet measurement | 3.27e-04 | 119 | 227 | 6 | EFO_0803541 | |
| Disease | Uveomeningoencephalitic Syndrome | 3.50e-04 | 4 | 227 | 2 | C0042170 | |
| Disease | Paroxysmal familial ventricular fibrillation | 3.50e-04 | 4 | 227 | 2 | C0340493 | |
| Disease | Klippel-Feil syndrome | 3.50e-04 | 4 | 227 | 2 | cv:C0022738 | |
| Disease | Congenital Heart Defects | 3.64e-04 | 44 | 227 | 4 | C0018798 | |
| Disease | migraine disorder | TRPM3 TRPM8 RAB3IL1 ONECUT2 JCAD AMBRA1 NBEA CNKSR2 MACF1 PHACTR1 | 4.79e-04 | 357 | 227 | 10 | MONDO_0005277 |
| Disease | Malignant melanoma of iris | 5.80e-04 | 5 | 227 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 5.80e-04 | 5 | 227 | 2 | C0346388 | |
| Disease | chemokine (C-X-C motif) ligand 1 measurement | 5.80e-04 | 5 | 227 | 2 | EFO_0008083 | |
| Disease | Hepatitis | 6.21e-04 | 22 | 227 | 3 | HP_0012115 | |
| Disease | melanoma | 7.09e-04 | 248 | 227 | 8 | C0025202 | |
| Disease | frailty measurement | 7.10e-04 | 23 | 227 | 3 | EFO_0009885 | |
| Disease | Brugada Syndrome (disorder) | 8.07e-04 | 24 | 227 | 3 | C1142166 | |
| Disease | Fuchs' endothelial dystrophy (is_implicated_in) | 8.66e-04 | 6 | 227 | 2 | DOID:11555 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 1.07e-03 | 100 | 227 | 5 | C0010606 | |
| Disease | congestive heart failure (is_implicated_in) | 1.15e-03 | 27 | 227 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | Common Migraine | 1.21e-03 | 7 | 227 | 2 | C0338480 | |
| Disease | immature platelet count | 1.39e-03 | 106 | 227 | 5 | EFO_0803544 | |
| Disease | Hematopoetic Myelodysplasia | 1.42e-03 | 29 | 227 | 3 | C2713368 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.60e-03 | 8 | 227 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.60e-03 | 8 | 227 | 2 | C0338479 | |
| Disease | urticaria (is_implicated_in) | 1.60e-03 | 8 | 227 | 2 | DOID:1555 (is_implicated_in) | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.60e-03 | 8 | 227 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 1.60e-03 | 8 | 227 | 2 | C0438414 | |
| Disease | Uveal melanoma | 1.60e-03 | 8 | 227 | 2 | C0220633 | |
| Disease | Myoclonic Absence Epilepsy | 1.60e-03 | 8 | 227 | 2 | C0393703 | |
| Disease | sickle cell anemia | 1.60e-03 | 8 | 227 | 2 | MONDO_0011382 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.60e-03 | 8 | 227 | 2 | C0393695 | |
| Disease | Leukemia, Megakaryoblastic, of Down Syndrome | 1.60e-03 | 8 | 227 | 2 | C1860789 | |
| Disease | Pruritus | 1.60e-03 | 8 | 227 | 2 | C0033774 | |
| Disease | immature platelet fraction | 1.92e-03 | 114 | 227 | 5 | EFO_0009187 | |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 2.05e-03 | 9 | 227 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | Myoclonic Epilepsy | 2.05e-03 | 9 | 227 | 2 | C0014550 | |
| Disease | Epilepsy, Myoclonic, Infantile | 2.55e-03 | 10 | 227 | 2 | C0917800 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.55e-03 | 10 | 227 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.55e-03 | 10 | 227 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | free androgen index | 2.58e-03 | 374 | 227 | 9 | EFO_0007005 | |
| Disease | coronary artery calcification | GABRG3 PDE3A ONECUT1 POFUT2 CACNA1E DOCK10 OSBPL3 DOCK7 EGFLAM PHACTR1 | 2.70e-03 | 450 | 227 | 10 | EFO_0004723 |
| Disease | endometriosis (implicated_via_orthology) | 3.10e-03 | 11 | 227 | 2 | DOID:289 (implicated_via_orthology) | |
| Disease | Myoclonic Astatic Epilepsy | 3.10e-03 | 11 | 227 | 2 | C0393702 | |
| Disease | Long QT Syndrome | 3.10e-03 | 11 | 227 | 2 | C0023976 | |
| Disease | Tachycardia, Ventricular | 3.10e-03 | 11 | 227 | 2 | C0042514 | |
| Disease | Congenital long QT syndrome | 3.10e-03 | 11 | 227 | 2 | cv:C1141890 | |
| Disease | psoriatic arthritis (is_implicated_in) | 3.10e-03 | 11 | 227 | 2 | DOID:9008 (is_implicated_in) | |
| Disease | Myopia | 3.12e-03 | 385 | 227 | 9 | HP_0000545 | |
| Disease | platelet measurement | 3.18e-03 | 315 | 227 | 8 | EFO_0005036 | |
| Disease | calcium measurement | PDE3A GCM2 FAM178B GAB2 GNA11 GNAQ MYO18B MYO18A HBP1 ABCC6 MACF1 ABCC12 | 3.62e-03 | 628 | 227 | 12 | EFO_0004838 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.70e-03 | 12 | 227 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | microphthalmia (implicated_via_orthology) | 3.70e-03 | 12 | 227 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 3.70e-03 | 12 | 227 | 2 | C3160718 | |
| Disease | Long QT syndrome | 3.70e-03 | 12 | 227 | 2 | cv:C0023976 | |
| Disease | Carcinoma, Transitional Cell | 3.86e-03 | 41 | 227 | 3 | C0007138 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 4.01e-03 | 194 | 227 | 6 | EFO_0004265, EFO_0007908 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 4.35e-03 | 13 | 227 | 2 | C0751122 | |
| Disease | Bardet-Biedl Syndrome | 4.35e-03 | 13 | 227 | 2 | C0752166 | |
| Disease | lymphocyte count | IL16 AKAP17A PSMD3 PTPN22 SFI1 GAB2 IQGAP1 TAF8 PTPN12 ALMS1 DDX18 POLR1B GNAQ OBI1 JCAD CARMIL2 DOCK10 ARHGEF18 JMJD1C SIGLEC1 HTT | 4.68e-03 | 1464 | 227 | 21 | EFO_0004587 |
| Disease | insulin measurement | 4.79e-03 | 267 | 227 | 7 | EFO_0004467 | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 5.03e-03 | 45 | 227 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 5.05e-03 | 14 | 227 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 5.05e-03 | 14 | 227 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | C-C motif chemokine 19 measurement | 5.05e-03 | 14 | 227 | 2 | EFO_0008047 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.23e-03 | 144 | 227 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.38e-03 | 145 | 227 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | DIS3L2 CYP19A1 AK5 BSN GCN1 MPP2 DIP2B RASGRF1 WDR70 JMJD1C CEP164 MADD ACTR1A G6PC3 CEP250 NPRL3 MACF1 | 5.50e-03 | 1106 | 227 | 17 | EFO_0021796 |
| Disease | Benign neoplasm of bladder | 5.79e-03 | 15 | 227 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.79e-03 | 15 | 227 | 2 | C0154091 | |
| Disease | Lymphoma, Large-Cell, Follicular | 5.79e-03 | 15 | 227 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 5.79e-03 | 15 | 227 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 5.79e-03 | 15 | 227 | 2 | C0079758 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.79e-03 | 15 | 227 | 2 | C0496930 | |
| Disease | Lymphoma, Follicular, Grade 2 | 5.79e-03 | 15 | 227 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 5.79e-03 | 15 | 227 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 5.79e-03 | 15 | 227 | 2 | C1956130 | |
| Disease | platelet component distribution width | GAB2 C2CD5 SIRPG KIF9 TRPM3 NPAS2 JCAD WEE1 DOCK10 JMJD1C DOCK7 MACF1 SIGLEC1 | 5.95e-03 | 755 | 227 | 13 | EFO_0007984 |
| Disease | cannabis dependence measurement | 6.02e-03 | 48 | 227 | 3 | EFO_0008457 | |
| Disease | small vessel stroke | 6.53e-03 | 96 | 227 | 4 | EFO_1001504 | |
| Disease | obesity (implicated_via_orthology) | 6.56e-03 | 215 | 227 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Romano-Ward Syndrome | 6.59e-03 | 16 | 227 | 2 | C0035828 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 6.59e-03 | 16 | 227 | 2 | OBA_2045090 | |
| Disease | sarcoidosis (is_implicated_in) | 6.59e-03 | 16 | 227 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | Seizures | 7.01e-03 | 218 | 227 | 6 | C0036572 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 7.43e-03 | 17 | 227 | 2 | C2936862 | |
| Disease | sphingomyelin 14:0 measurement | 7.43e-03 | 17 | 227 | 2 | EFO_0010390 | |
| Disease | coronary artery disease (is_implicated_in) | 7.52e-03 | 100 | 227 | 4 | DOID:3393 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLELFEEMRSTRRVS | 201 | Q9P2W7 | |
| FERRSSSIAVLRMKA | 301 | Q15699 | |
| NTTRERRDMILNFAE | 131 | O60825 | |
| QRLSRSFLSRSNMSV | 316 | P53355 | |
| SSIRKAVRIAFDRAM | 1026 | O95696 | |
| RDVRFDLSAQQMKTR | 11 | Q8N3I7 | |
| RSAVRVSIAISRMKF | 3766 | Q99996 | |
| TRLRDFQERLSMKDQ | 811 | Q6ZSZ5 | |
| DFMSLAIIRRSLQFR | 436 | Q63HQ2 | |
| SESLREFMRQKAQAR | 636 | A0A096LP49 | |
| ERAQDLRRTNSLMVS | 976 | Q15878 | |
| SMRRSFSTIRDKRSN | 2016 | Q15878 | |
| RLQMSERSILSRLTN | 1891 | Q8TDI0 | |
| FSTQMERVRTLTDVR | 1021 | Q9NZJ5 | |
| VSTLRNTRMLAFKAT | 721 | Q9UHX3 | |
| QDAFTRLRDMRLSIT | 856 | Q6F5E8 | |
| TNTHQFDRESLMRRR | 1156 | Q6V0I7 | |
| EQSRNSLRKESLIFM | 331 | Q0P651 | |
| RKLQSMLQTERDALF | 4066 | Q8TCU4 | |
| NDMALAKRSRSRTAT | 146 | Q69YQ0 | |
| MIQYLSRRDSIRQRS | 731 | Q9C0C7 | |
| DRRMASKRVQELSTS | 741 | Q8IYB7 | |
| VRMARSFHRTQDLKT | 51 | Q14692 | |
| LRFNTEARLRTQEMA | 556 | A6NI56 | |
| LSAALSSLQRDMQRL | 706 | Q9P1Y5 | |
| EEMRTFQSRTLALSR | 796 | Q2TAZ0 | |
| LAILDFNSDRKRMSI | 591 | O43520 | |
| RATNMTVSAIRFLKT | 151 | P23786 | |
| LDSSIRNMRAVTDKF | 1131 | P46940 | |
| RNMRAVTDKFLSAIV | 1136 | P46940 | |
| AAQLDVLRLRSSSME | 56 | Q8TBN0 | |
| SLRLNNSVSRFKLRM | 946 | Q9Y2K5 | |
| NMIELSRRRFETANL | 81 | Q9NTZ6 | |
| SSEVLSERRNSLRRM | 1006 | Q9H0J4 | |
| LTRMRSNLLKSTRRF | 556 | Q9UL03 | |
| FSVFSLIREMRTQRP | 256 | Q9Y2R2 | |
| NRMEESKALFRTIIT | 246 | P50148 | |
| RNERAMLASRSASLL | 161 | Q99811 | |
| RRDQFNVLIKELSSM | 21 | Q99743 | |
| MARNTLSSRFRRVDI | 1 | Q9BPX5 | |
| TLDMRAFLRNSQVER | 5201 | Q99102 | |
| VVRAEIMRSLSFSTN | 166 | P01566 | |
| IMRSLSFSTNLQKRL | 171 | P01566 | |
| TRESSLKRRLFRSMF | 251 | Q9NQU5 | |
| VVRAEIMRSLSFSTN | 166 | P01570 | |
| IMRSLSFSTNLQKRL | 171 | P01570 | |
| FARSQLTEMRRTLQT | 301 | Q7Z3Y7 | |
| EASLSVQMSRRVRAL | 416 | Q9HCP6 | |
| LRMFERRSFETQLSR | 521 | Q9Y561 | |
| QRRMSLRDDTSFVFT | 66 | Q8WXG6 | |
| TSAKLSRAEQRMNRL | 251 | Q99435 | |
| QSEMRRKSDLLRTLT | 356 | Q68DU8 | |
| DTMTNRLLQRSRSSL | 491 | Q9Y6K8 | |
| QIKDRVTMASAFRLS | 151 | Q9BXM9 | |
| QKFQDRVTITRDRSM | 81 | A0A0A0MS14 | |
| NKNFERLRSSMSENR | 151 | Q6DN90 | |
| SSVSRMRVLSFRNAD | 1266 | Q9P266 | |
| MNCSESQRLRTLLSR | 1 | Q9UJ90 | |
| MQLASKDRVSERSSA | 1321 | Q15652 | |
| MTALSSQVATRARSR | 126 | Q9BUM1 | |
| IMRSFSLSKIFQERL | 171 | P01568 | |
| RESRVQRSRMDSSVS | 361 | O15054 | |
| EFLMENSSRQRAFRK | 1841 | Q8IVV2 | |
| SIVRMRQASSRDLAF | 1266 | Q9UPA5 | |
| KGRRSRTVFTELQLM | 141 | Q9HBU1 | |
| MAKSRRLERSTNSFS | 121 | Q8WXQ8 | |
| NLELRRLVETMRFTS | 706 | Q9P219 | |
| RLVETMRFTSTKLAQ | 711 | Q9P219 | |
| KQSLRASRIRAEMFA | 181 | O94992 | |
| MFSSNRQKILERTEI | 41 | Q15910 | |
| RSRLTRATRQEMLFL | 6 | P10720 | |
| QVFRNQDTRMTSRLK | 396 | A0A0J9YXQ4 | |
| FIRTLEAQRSFSMRD | 1371 | Q9UIW2 | |
| MQFSSEEKRTLLARL | 231 | Q9ULD0 | |
| MATASREERLKALNT | 226 | Q9H344 | |
| QLALRRATSMRKTFT | 996 | Q92614 | |
| FKRRRRSSSVVSAEM | 286 | Q14432 | |
| VVRAEIMRSFSLSAN | 166 | P01569 | |
| IMRSFSLSANLQERL | 171 | P01569 | |
| RRSQLLMLFDKFRSV | 536 | Q12980 | |
| QMVSAQERLTRTFTR | 2166 | Q14315 | |
| LSTVSNFFMNARRRS | 426 | Q9UBC0 | |
| RRAQKVMIRSSSDSS | 501 | Q14005 | |
| RMSNSFTAIAKLLTR | 351 | Q14D04 | |
| SKRSLRNFRLNSSDM | 1466 | Q6KC79 | |
| LNSIRSFEMNRTRTS | 511 | Q5W0B1 | |
| ELTTVSNFFMNARRR | 466 | O95948 | |
| SQTLMRLLRSREAAA | 1106 | Q9P265 | |
| SMSVNLTRRTLDRCQ | 246 | P18074 | |
| RSSLLLGFRRSMNIN | 541 | P42704 | |
| EQIMLSAAVRRTSRD | 531 | Q8WTR4 | |
| SRVLSALSDRQMSER | 681 | Q96RT7 | |
| QRAFQDRSTDTRKMA | 1621 | Q92616 | |
| RTFRELQTAMEKLRT | 551 | Q14168 | |
| ETLSSLRFASRMKLV | 326 | Q9HAQ2 | |
| SLRKLQQEMDSLTFR | 51 | Q6ZMI0 | |
| TRRQTMLFSATQTRK | 356 | Q9NVP1 | |
| NRAQMLTRDRAFEST | 941 | Q86XP1 | |
| NSVFRLGLRRLSETM | 321 | Q9Y2T5 | |
| RSSKMRRLSSRAQSE | 236 | Q6NV74 | |
| QRVSMSRNIESRSTS | 66 | Q96PD4 | |
| RRRMLSSSDAITQEF | 1371 | Q9UPN3 | |
| DNTLRETMVSAIRKF | 751 | Q5TIA1 | |
| TSAALERKISMRQSR | 136 | Q9C0D0 | |
| RSISERRAAMENQRS | 426 | Q9UQ26 | |
| NRSLALVMSQARFEK | 196 | Q8N414 | |
| MILQRLFRFSSVIRS | 1 | P18859 | |
| QTSLSLNSEDFMRRK | 396 | A8MPY1 | |
| FLSTNMQERLRSKDR | 176 | P05000 | |
| MFRRITAAATRLFRS | 1791 | P42858 | |
| KVQTERTRSMLLFAN | 266 | A6NGN9 | |
| RKTQGFLTMSRRRIS | 21 | Q8WWN9 | |
| MSNELDFRSVRLLKN | 1 | Q8TE85 | |
| QMRSNIIYDSTARIR | 301 | O95393 | |
| DTVKTTRNMERLNLF | 346 | Q96BY6 | |
| MAERRAFAQKISRTV | 1 | Q96N67 | |
| LRRVMLDTSNTLFLR | 191 | P11511 | |
| SRRSIRSSQNVAMIF | 146 | P24387 | |
| RLRFNSTMKILTLNS | 106 | Q99928 | |
| RAFEQLMTDLTLSRV | 31 | Q6UUV7 | |
| SLELFQEMRTTRKVS | 191 | Q9NPZ5 | |
| NRMEESKALFRTIIT | 246 | P29992 | |
| TMASLQSRLRRAELQ | 1321 | Q9BV73 | |
| EKAIRMSRSRINDAF | 701 | Q9BYF1 | |
| SDMDLRRTLFSNIVL | 286 | P61163 | |
| TRQMRSSLSADLRQA | 1416 | Q7Z591 | |
| MLSTSRSRFIRNTNE | 1 | P41597 | |
| ISSDQRMLTNRQLSR | 621 | O75165 | |
| NRTASVATLRMKARE | 201 | A6NNA5 | |
| MREFRSGSSRVLITT | 316 | Q14240 | |
| VRAEIMRSFSLSTNL | 166 | P01563 | |
| QALLRKSREAESMAT | 326 | Q9NS73 | |
| AVYVLSSMARQRRAS | 366 | O60381 | |
| EMIDKLTLTFNRTRQ | 266 | P36542 | |
| TNTRSFDRMVREAQL | 686 | Q9NQR7 | |
| QRLRQADRASSFSSM | 226 | P54792 | |
| QADLSSRSRMAARLL | 166 | Q5T7N8 | |
| DSMALYNRTRRISQT | 2796 | Q92736 | |
| LFRAIRSAVTVMLSN | 86 | Q8IZU8 | |
| SSRIRFMLQDVIDLR | 966 | O43432 | |
| RASNEARQRLISLMS | 186 | Q86YS7 | |
| SFAKSRQMRSVDVTL | 46 | P07358 | |
| VVRAEIMRSLSFSTN | 166 | P01571 | |
| RRQFQSLDTTMRRLI | 381 | O95954 | |
| TLRSAFNIMSAEREK | 346 | Q9H4L5 | |
| SIIRSRMVLRATEAF | 71 | Q9BXW4 | |
| GRLRSFSMQDLRSIS | 146 | Q9H6H4 | |
| VVRAEIMRSFSSSRN | 166 | P05013 | |
| IMRSFSSSRNLQERL | 171 | P05013 | |
| DMRRALFSSLLRQDI | 226 | Q9NUT2 | |
| ILAMASTQSRRKVFS | 226 | Q8NGE3 | |
| RASFLMRSDTAVQKL | 216 | Q9UQC2 | |
| FTRSQRKNLFAEMRE | 281 | Q6KF10 | |
| ERQRRKSSLMFSSRT | 251 | Q9H3N8 | |
| LEMSKTEALTQAFRR | 111 | Q9Y230 | |
| SDMKVARSATARVRS | 206 | Q92665 | |
| LMRDNLFEIITSSRT | 261 | Q9HB19 | |
| TMLDFRTSKFVLRIS | 296 | Q15542 | |
| SQRRDVERALTRFMA | 181 | Q7Z7C8 | |
| RRTKLQMQTTALEFR | 201 | A8K8P3 | |
| TRLLRFAASMKASRQ | 891 | A8K8P3 | |
| DTFAESLIRRMAQSV | 61 | Q8NEY4 | |
| SLDNVLRTMLRRFAR | 131 | Q8NBS3 | |
| MERKSIAFRSNELLR | 466 | Q96JX3 | |
| MSDTAVADTRRLNSK | 1 | Q9UMY4 | |
| FNRQMVARSLLDTLR | 61 | Q8TF05 | |
| RSLQQQFSRMEETVR | 106 | O14513 | |
| LLRNTSARSVMLDRA | 206 | Q9Y2G5 | |
| MRQKDSRARLTSSIL | 481 | O95255 | |
| RNMALEVFSRTKAQL | 381 | Q7Z6Z6 | |
| FRMVIRKDSRTAFSD | 431 | Q9NTG1 | |
| QFFPDMTSRSRRLRS | 511 | Q8IXR5 | |
| MKALRELDRFSVLNS | 331 | Q9NYY8 | |
| RLFLSDMIKLFSNSR | 866 | Q8NFP9 | |
| SETEARRSAIKRQMA | 166 | O75603 | |
| MSYSDESRLSNLLRR | 141 | Q96Q15 | |
| RFRNSSMSLDEKSRT | 1606 | Q8IVL1 | |
| DNFARDFMRLRRLST | 26 | Q05209 | |
| MSEARRDSTSSLQRK | 1 | Q96CC6 | |
| MSNLSVLRSFRLLRV | 801 | Q14524 | |
| RQRAMSRASILTNTV | 686 | Q15858 | |
| LRSMRSLDFSTRTQI | 166 | Q92529 | |
| RLRQLMQRSLSESDT | 666 | Q9Y6H5 | |
| ALRRSLSRSMSQEAQ | 151 | O15273 | |
| LRAKTRDFTSSRMVV | 1921 | P11055 | |
| IADFLRSRRIMSTTN | 361 | Q9P2U7 | |
| ERLRSFSMQDLTTIR | 146 | Q9H902 | |
| VVRAEIMRSLSFSTN | 166 | P05014 | |
| IMRSLSFSTNLQKRL | 171 | P05014 | |
| LRRIASTMAKDVRQF | 191 | Q6ZRS2 | |
| VSDLTKRNNMDFSIR | 91 | Q9P1W8 | |
| KRNNMDFSIRISSIT | 96 | Q9P1W8 | |
| RAALLTERTRNEMTA | 456 | Q9Y5B9 | |
| FSIKAMAEANVSLRR | 396 | Q96J65 | |
| EITSSMNRSAIFRLK | 1131 | Q13972 | |
| RNGIRTQDMRLTFTL | 1716 | O60287 | |
| FSKSADERQRMLVQR | 571 | Q9UKV5 | |
| TLRISKSTMDFIRFE | 66 | Q02040 | |
| RSAKEFLVQQTRSMR | 1111 | Q9UPV0 | |
| VRASMRSSFERQNRS | 66 | Q8IZM0 | |
| DSRRENSLLRYMSNE | 461 | Q8WXI2 | |
| ALQRSRMVARSSDTA | 1431 | Q9Y4G8 | |
| LQSRARYTSEMRSEL | 111 | Q9NZ43 | |
| RRELTLGQIRSSTMS | 181 | Q8WWB5 | |
| KRELTNERYIRTSNM | 2251 | Q86UP3 | |
| RALFTDRMATRSTTQ | 611 | P30291 | |
| SLRIFSVSRTAMELK | 1506 | Q96KV7 | |
| PMRSRIREFDSSTLN | 41 | Q96EC8 | |
| EYSEARRTMTNALRK | 301 | O43242 | |
| LRSFSMQDLTLIRDE | 146 | Q9BRK0 | |
| ESSSLQKRMRSVLDR | 501 | Q9NXB0 | |
| SQKQLSSLRDRMVAF | 766 | Q9UJ98 | |
| IEVLRSMRSLDFNTR | 161 | P98077 | |
| SMRSLDFNTRTQVTR | 166 | P98077 | |
| LFTSRFKDRIVSMTL | 366 | Q8N3U4 | |
| TLSLFMRNKRATDSQ | 66 | Q7RTT6 | |
| RFLTSMRRLSSIKRD | 71 | O75558 | |
| MRRLSSIKRDTNSIA | 76 | O75558 | |
| SMRRFSLLKRESTIT | 81 | Q8N4C7 | |
| DSLSMRRLSRTSAFQ | 1711 | Q9HCF6 | |
| AMFEQTRRTAVERSR | 41 | Q9NW82 | |
| RSSEMRRKLLAVSAS | 26 | P0C7P2 | |
| REMLAISFISAVNRK | 1161 | Q9P227 | |
| LTLLRFSFDLRTMRR | 806 | Q9P2H5 | |
| MNTVSAREKLSAFVR | 396 | Q8IZ13 | |
| QAASLRTSDLRKMVD | 211 | P12271 | |
| LSSFRDSRARSMAVI | 1351 | Q9BZZ2 | |
| RSRMVRRTFASSLAA | 1156 | Q8IUG5 | |
| LSIVREMFKRRDSNA | 351 | A7E2V4 | |
| KTFSSRRNLRRHMVV | 176 | Q8TA94 | |
| LMRFSIRNSQTRKIC | 256 | Q3LFD5 | |
| ILFMERSTLNRHQRT | 191 | Q8IVP9 | |
| ERKEAASRLRMAQTS | 121 | Q9BXU3 | |
| RFMVLTSERLFAQRE | 141 | Q6NX49 | |
| RNTMLEREIAFSIRD | 141 | Q5GH77 | |
| LMRFSIRNSQTRKIC | 256 | Q9UMW8 | |
| SLQDITMRKAFRSST | 91 | Q92558 | |
| ARLSMRNRRNDTLDS | 6 | Q7Z2W7 | |
| ADFAKMRTTTVRRLL | 476 | Q9H9Y6 | |
| RLRHMVSDKFQVRTT | 1001 | Q9H9Y6 | |
| TRFRMEELRLTSTTF | 151 | Q8WY21 | |
| RAKRMSFRLANSISQ | 1201 | O15016 | |
| RVEFMDDTSRSIIRN | 31 | P62857 | |
| CSREMQSSFTRRDLN | 661 | Q96RL1 | |
| REFTLVRRLMNISSV | 276 | Q8N8C0 | |
| MRALDFNTRTQVTRE | 176 | P29353 | |
| QSREVEMSTRDRFQL | 91 | Q96RL6 | |
| IKASTEMRLRRFQSV | 106 | Q9NXG2 | |
| STNRLRDFKETVSNM | 501 | Q70EL1 | |
| NTVELLRMSVDSRFR | 206 | Q8N9F0 |